The headline and deck on the Dec. 15 online version of New York Times correspondent Sheryl Gay Stolberg’s article about pressure on HHS to act on drug manufacturers’ denials of 340B pricing.
The New York Times, Often a Public Policy Shaper, Runs Article on 340B Pricing Denials
The New York Times has published a news article about “top pharmaceutical companies [that] have stopped giving federally mandated drug discounts to hospitals and clinics that care for the poorest Americans,” and the bipartisan pressure building on outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar “to demand reinstatement of the price breaks or punish the firms.”
The story by the newspaper’s Washington correspondent Sheryl Gay Stolberg, who focuses on health care policy, first ran online early last night and today in the print edition’s business section.
.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
×